Constance, Germany

Thomas Martin


Average Co-Inventor Count = 1.5

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Konstanz, DE (2000)
  • Constance, DE (2000 - 2008)

Company Filing History:


Years Active: 2000-2008

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Thomas Martin

Introduction

Thomas Martin, an accomplished inventor based in Constance, Germany, has made significant strides in the field of pharmaceutical innovations. With a notable portfolio of 12 patents, Martin has dedicated his career to the development of novel compounds that address various medical challenges.

Latest Patents

Among his recent innovations are two groundbreaking patents. The first is for imidazo[4,5-b]quinoline-derivatives, which serve as effective inhibitors of nitric oxide synthase (iNOS). These compounds, characterized by specific structural features outlined in the patent description, provide a promising avenue for therapeutic applications. The second patent focuses on tryptase inhibitors, comprising compounds that demonstrate potential in inhibiting the enzyme tryptase, with implications for various health conditions. Both patents reflect Martin's commitment to advancing medicinal chemistry.

Career Highlights

Throughout his career, Thomas Martin has held pivotal roles at Altana Pharma AG and Byk Gulden Lomberg Chemische Fabrik GmbH. His work at these esteemed companies has been instrumental in fostering innovation in pharmaceutical research and product development. Martin's expertise in developing inhibitors has significantly contributed to the advancement of therapeutic options available in the market.

Collaborations

In his professional journey, Martin has collaborated with prominent researchers, including Wolf-Rudiger Ulrich and Thomas Bär. These partnerships demonstrate his commitment to teamwork and the collective advancement of science. Through these collaborations, they have pushed the boundaries of their research, leading to notable advancements in their respective fields.

Conclusion

In summary, Thomas Martin stands out as a prominent inventor in the realm of pharmaceutical innovations. His impressive array of patents, including recent advancements in iNOS and tryptase inhibitors, showcases his commitment to improving health outcomes through novel chemical solutions. With a robust career characterized by collaborations with other innovators, Martin is poised to continue making impactful contributions to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…